Therapeutic Apheresis and Dialysis最新文献_第5页

The effect of video-based fistula care education on hemodialysis patients' self-care behaviors: A randomized controlled study. 基于视频的瘘管病护理教育对血液透析患者自我护理行为的影响：一项随机对照研究。

IF 1.9 4区医学

Therapeutic Apheresis and Dialysis Pub Date : 2023-12-01 Epub Date: 2023-08-27 DOI: 10.1111/1744-9987.14058

Seda Şahan, Ayşegül Yıldız, Cevriye Özdemir, Elif Günay İsmailoğlu

{"title":"The effect of video-based fistula care education on hemodialysis patients' self-care behaviors: A randomized controlled study.","authors":"Seda Şahan, Ayşegül Yıldız, Cevriye Özdemir, Elif Günay İsmailoğlu","doi":"10.1111/1744-9987.14058","DOIUrl":"10.1111/1744-9987.14058","url":null,"abstract":"Objective: This study aimed to determine the effect of face-to-face and video-based education for fistula care on hemodialysis patients' self-care behaviors.Methods: The study was conducted as a randomized controlled experimental study. Accordingly, 60 patients were included in the study for 95% strength. Fistula care training was given to the patients in the control group using face-to-face education technique. Fistula care training was given to the patients in the experimental group using a video-based technique.Results: The analysis showed that the post-test second week (p = 0.044) and fourth week (p = 0.00) mean scores of the experimental group were higher compared to those of the control group.Conclusion: These results showed that the video-based education given to hemodialysis patients was more memorable and instructive than the verbal education, and it was observed that the video-based education showed a higher level of success in developing self-care skills.","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":" ","pages":"1095-1102"},"PeriodicalIF":1.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10439690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Evaluation of the treatment volume and removal rate of Rheocarna: A novel adsorption-type blood purification device for patients with chronic limb-threatening ischemia. Rheocarna治疗量和去除率的评估：一种新型吸附型血液净化装置，用于慢性肢体威胁性缺血患者。

IF 1.9 4区医学

Therapeutic Apheresis and Dialysis Pub Date : 2023-12-01 Epub Date: 2023-08-17 DOI: 10.1111/1744-9987.14050

Atsushi Ohkubo, Takatoshi Sakurasawa, Yuki Hoshikawa, Mana Usui, Misaki Hoshi, Takuto Shiga, Masaya Deushi, Shigeto Komori, Ayako Itagaki, Hiroko Yamamoto, Hiroshi Seshima, Naoki Kurashima, Soichiro Iimori, Shotaro Naito

{"title":"Evaluation of the treatment volume and removal rate of Rheocarna: A novel adsorption-type blood purification device for patients with chronic limb-threatening ischemia.","authors":"Atsushi Ohkubo, Takatoshi Sakurasawa, Yuki Hoshikawa, Mana Usui, Misaki Hoshi, Takuto Shiga, Masaya Deushi, Shigeto Komori, Ayako Itagaki, Hiroko Yamamoto, Hiroshi Seshima, Naoki Kurashima, Soichiro Iimori, Shotaro Naito","doi":"10.1111/1744-9987.14050","DOIUrl":"10.1111/1744-9987.14050","url":null,"abstract":"Introduction: Chronic limb-threatening ischemia (CLTI) is a clinical syndrome defined by peripheral arterial disease (PAD) combined with rest pain, gangrene, or leg ulceration for longer than two weeks resulting in lower extremity amputation. In recent years, low-density lipoprotein apheresis (LDL-A) has been implemented for PAD treatment. However, it has not been possible to ensure insurance coverage for patients with lower LDL levels than 140 mg/dL under cholesterol-lowering drugs. Rheocarna is a novel adsorption-type blood purification device for the treatment of CLTI by adsorbing LDL and fibrinogen (Fib) that is not constrained by hypercholesterolemia and is not amenable to or nonresponsive to revascularization surgery. The only requirements for use are that the blood flow rate increases up to 200 mL/min gradually.Methods: To evaluate the applicability of this treatment procedure, we compared the removal rates of Fib and LDL following Rheocarna therapy using various blood treatment volumes (6, 10.5, and 19.5 L).Results: Fib and LDL removal rates were about 20% and 15%-25% per treatment, with no significant differences between treatment volumes. Following treatment with Rheocarna, blood pressure tends to decrease at first, which later increases, and the higher the treatment volume, the longer the time of low blood pressure tended to be.Conclusion: Although no significant difference was found in the removal rate of Fib and LDL in response to increase volume to 6 L or beyond in this study, the 6 L volume is considered effective enough for the removal of Fib and LDL.","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":" ","pages":"1017-1022"},"PeriodicalIF":1.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10005512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Water quality and adverse health effects on the hemodialysis patients: An overview. 血液透析患者的水质和不良健康影响：综述。

IF 1.9 4区医学

Therapeutic Apheresis and Dialysis Pub Date : 2023-12-01 Epub Date: 2023-06-28 DOI: 10.1111/1744-9987.14032

Raquel Raimundo, Laura Preciado, Rita Belchior, Cristina M M Almeida

引用次数: 0

Novel and highly reliable leak check tests for drop- and external pressure-type cell-free and concentrated ascites reinfusion therapy. 适用于滴注和外压型无细胞和浓缩腹水回输治疗的新型和高度可靠的渗漏检查测试。

IF 1.9 4区医学

Therapeutic Apheresis and Dialysis Pub Date : 2023-12-01 Epub Date: 2023-08-18 DOI: 10.1111/1744-9987.14048

Yasuko Kobayashi, Nana Ozawa, Tamami Yoshida, Takashi Minowa, Yuki Michinaga, Keita Inui, Koji Hashimoto, Yuji Kamijo

{"title":"Novel and highly reliable leak check tests for drop- and external pressure-type cell-free and concentrated ascites reinfusion therapy.","authors":"Yasuko Kobayashi, Nana Ozawa, Tamami Yoshida, Takashi Minowa, Yuki Michinaga, Keita Inui, Koji Hashimoto, Yuji Kamijo","doi":"10.1111/1744-9987.14048","DOIUrl":"10.1111/1744-9987.14048","url":null,"abstract":"Introduction: For safe management of cell-free and concentrated ascites reinfusion therapy (CART), a highly reliable leak test for detecting ascites filter damage is essential. However, such a test has not been established for drop-type CART.Methods: We devised two novel leak tests for drop- and external pressure-type CART, manual or pump pressurization methods, using high-pressure loading and pressure monitoring, and investigated their reliability.Results: Both methods could easily load and maintain sufficiently high pressure (>400 Torr) on the hollow fibers for 2 min. No result deviation was noted between different operators. The pressure drops in both methods were identical and significantly lower than those in the leak test using a special CART machine, the e-CART.Conclusion: The reliability of our revised leak test is equivalent to that of the automatic leak test of e-CART. These highly reliable leak tests may contribute to safety in patients undergoing drop- and external pressure-type CART.","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":" ","pages":"1040-1047"},"PeriodicalIF":1.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10021308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Rescue plan for CAPD peritonitis: Using ultrasonography as a guide on when to remove the catheter. CAPD腹膜炎的抢救计划：使用超声波作为何时移除导管的指南。

IF 1.9 4区医学

Therapeutic Apheresis and Dialysis Pub Date : 2023-12-01 Epub Date: 2023-08-26 DOI: 10.1111/1744-9987.14042

Dusit Lumlertgul, Nantawan Tinroongroj, Suthaporn Lumlertgul, Pannamart Siwapitak, Rattanaluck Tungkanakorn, Supaporn Kaewpanya

{"title":"Rescue plan for CAPD peritonitis: Using ultrasonography as a guide on when to remove the catheter.","authors":"Dusit Lumlertgul, Nantawan Tinroongroj, Suthaporn Lumlertgul, Pannamart Siwapitak, Rattanaluck Tungkanakorn, Supaporn Kaewpanya","doi":"10.1111/1744-9987.14042","DOIUrl":"10.1111/1744-9987.14042","url":null,"abstract":"Introduction: Ultrasound has been found to facilitate early identification of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).Methods: A retrospective analysis was carried out to evaluate the effectiveness of ultrasonography-guided removal of the Tenckhoff catheter in reducing complications like a shift to hemodialysis or death in CAPD patients.Results: The \"peritonitis rescue plan\" supported timely decision-making for the removal of the infected catheter and resulted in a lower peritonitis episode per patient per month ratio (from 1:36 to 1:122) in 2021, a lower death rate (from 19% to 6.6%) and lower incidences of shifts to hemodialysis (from 2%-9% to 0%) as compared to that before the implementation of the plan in 2019.Conclusion: The implementation of the \"peritonitis rescue plan\" and the removal of the infected catheter within 3 days of peritonitis being detected was successful in improving the standard of care for patients undergoing CAPD.","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":" ","pages":"1113-1124"},"PeriodicalIF":1.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10076298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Geriatric Depression Scale predicts mortality in elderly patients on chronic hemodialysis. 老年抑郁量表预测老年慢性血液透析患者的死亡率。

IF 1.9 4区医学

Therapeutic Apheresis and Dialysis Pub Date : 2023-12-01 Epub Date: 2023-07-12 DOI: 10.1111/1744-9987.14036

Maurizio Bossola, Gilda Pepe, Emanuela Antocicco, Camilla Illuminati, Enrico Di Stasio

{"title":"Geriatric Depression Scale predicts mortality in elderly patients on chronic hemodialysis.","authors":"Maurizio Bossola, Gilda Pepe, Emanuela Antocicco, Camilla Illuminati, Enrico Di Stasio","doi":"10.1111/1744-9987.14036","DOIUrl":"10.1111/1744-9987.14036","url":null,"abstract":"Introduction: The aim of this study was to determine if the Geriatric Depression Scale (GDS) was predictor of mortality in elderly patients on chronic hemodialysis (HD).Methods: A total of 140 HD patients ≥65 years were studied. Symptoms of depression were assessed through GDS and cognitive function through the Mini Mental State Examination (MMSE). GDS scores 0-9 are considered normal (Group 1); scores of 10-20 (Group 2) and 21-30 (Group 3) indicate mild and severe depression.Results: Median GDS was 13 (11-15): 54 patients in Group 1, 49 in Group 2, and 37 in Group 3. After a follow-up of 58.85 ± 38.8 months, 94 patients died and 46 were alive. Kaplan-Meier survival was significantly lower in patients of Groups 2 and 3 than in Group 1 (log-rank χ2 : 101.9; DF: 2; p < 0.0001). According to Cox regression analysis, mortality was associated with age and GDS, and inversely associated with MMSE and Kt/V.Conclusion: GDS predicts mortality in elderly HD patients.","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":" ","pages":"1088-1094"},"PeriodicalIF":1.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9764290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Current status of low-density lipoprotein apheresis treatment for patients with peripheral artery disease and chronic kidney disease in Japanese clinical database. 日本临床数据库中外周动脉疾病和慢性肾脏疾病患者单采低密度脂蛋白治疗的现状。

IF 1.9 4区医学

Therapeutic Apheresis and Dialysis Pub Date : 2023-12-01 Epub Date: 2023-08-16 DOI: 10.1111/1744-9987.14046

Yu Watanabe, Akihito Tanaka, Kazuhiro Furuhashi, Shoichi Maruyama

{"title":"Current status of low-density lipoprotein apheresis treatment for patients with peripheral artery disease and chronic kidney disease in Japanese clinical database.","authors":"Yu Watanabe, Akihito Tanaka, Kazuhiro Furuhashi, Shoichi Maruyama","doi":"10.1111/1744-9987.14046","DOIUrl":"10.1111/1744-9987.14046","url":null,"abstract":"Introduction: Patients with peripheral arterial disease (PAD) have a poorer prognosis than those without PAD. PAD complications worsen the prognosis of patients with chronic kidney disease (CKD), especially those on maintenance dialysis. Although low-density lipoprotein apheresis (LDL-A) is expected to be effective in treating severe PAD, there are no large-scale reports on the prognosis of patients undergoing LDL-A.Methods: We obtained a clinical database from April 2008 to August 2021 and selected 924 238 patients with CKD. We selected patients with disease codes of lower limb arteriosclerosis obliterans, arteriosclerosis obliterans, and critical limb ischemia or foot ulcer. Patients who were prescribed antithrombotic medications were included. Patients who used steroids were excluded. Among these patients, those undergoing blood purification considered LDL-A were selected, and their current status was investigated.Results: We included 147 patients (113 males and 34 females). The mean patient age was 70 ± 10 years. Diabetes mellitus was present in 86%, ischemic heart disease in 34%, and stroke in 48%. Maintenance dialysis patients accounted for 86% of the patients. Statins were administered to 40% of the patients, and bypass surgery was performed in 2.7%. The median observation period was 812 days, and the mortality rate was 41%.Conclusion: LDL-A was performed in a small population of patients with CKD with the most severe form of PAD. The prognosis for these patients is extremely poor. Therefore, strategies to improve prognosis are important.","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":" ","pages":"1000-1009"},"PeriodicalIF":1.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10367850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Correction to "Impact of weekly teriparatide on the bone and mineral metabolism in hemodialysis patients with relatively low serum parathyroid hormone: A pilot study". 更正“每周特立帕肽对血清甲状旁腺激素相对较低的血液透析患者骨和矿物质代谢的影响：一项初步研究”。

IF 1.9 4区医学

Therapeutic Apheresis and Dialysis Pub Date : 2023-12-01 Epub Date: 2023-08-30 DOI: 10.1111/1744-9987.14044

引用次数: 0

Retrospective observational study of changes in serum cytokines and adiponectin with continuous plasma exchange with dialysis therapy for severe COVID-19. 持续血浆置换透析治疗重症新冠肺炎患者血清细胞因子和脂联素变化的回顾性观察研究。

IF 1.9 4区医学

Therapeutic Apheresis and Dialysis Pub Date : 2023-12-01 Epub Date: 2023-08-31 DOI: 10.1111/1744-9987.14054

Yuya Suzuki, Hajime Nakae, Kasumi Satoh, Nobuhisa Hirasawa, Komei Kameyama, Yasuhito Irie, Toshiharu Kitamura, Tasuku Nara, Kyohei Maeno, Kenji Yoshida, Manabu Okuyama

{"title":"Retrospective observational study of changes in serum cytokines and adiponectin with continuous plasma exchange with dialysis therapy for severe COVID-19.","authors":"Yuya Suzuki, Hajime Nakae, Kasumi Satoh, Nobuhisa Hirasawa, Komei Kameyama, Yasuhito Irie, Toshiharu Kitamura, Tasuku Nara, Kyohei Maeno, Kenji Yoshida, Manabu Okuyama","doi":"10.1111/1744-9987.14054","DOIUrl":"10.1111/1744-9987.14054","url":null,"abstract":"Introduction: Coronavirus disease 2019 (COVID-19) is associated with a marked increase in the inflammatory cytokines, IL-6 and IL-18. Blood purification therapy aimed at controlling cytokines is one treatment option; however, evidence of its effectiveness is needed. Plasma exchange with dialysis (PED) is a blood purification method involving selective plasma exchange with dialysate flowing through the outer hollow fiber of the plasma separator. In this retrospective study, we investigated the efficacy of continuous PED (cPED) over 48 h in five patients with severe COVID-19.Methods: We assessed changes in IL-6 and IL-18, as well as adiponectin (APN).Results: There were no significant differences in changes in IL-6 and IL-18, but there was a marked improvement in cases with abnormally high IL-6 and IL-18 levels at baseline. APN, which inhibits inflammatory cytokines, was significantly elevated post-cPED.Conclusion: Our results suggest that cPED therapy is an effective treatment for COVID-19.","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":" ","pages":"1028-1034"},"PeriodicalIF":1.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10124519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Double filtration plasmapheresis for bullous pemphigoid: Outcomes from the evaluation of eight patients. 双重过滤血浆置换治疗大疱性类天疱疮：8例患者的评价结果。

IF 1.9 4区医学

Therapeutic Apheresis and Dialysis Pub Date : 2023-12-01 Epub Date: 2023-08-15 DOI: 10.1111/1744-9987.14052

Hisao Kawahira, Kazuyasu Fujii, Yuko Higashi, Yasutoshi Yamada, Akihiko Mitsuke, Hideki Enokida, Takuro Kanekura

引用次数: 0